Conflict of Interest
Outside of the submitted work: Stefan Holdenrieder has received
grants from Roche Diagnostics, Sysmex and Volition, consulting fees from
Instand e.V, EQAS, Merck KG, Roche Diagnostics and Thermo Fisher
Scientific, speaker’s honoraria from BMS, Medica, Roche Diagnostics and
Trillium, and has leadership roles in the International Society of
Oncology and Biomarkers (board member and secretary), DGKL Competence
Field Molecular Diagnostic (vice speaker) and Federal Medical
Association, D5 Group (delegate of the DGKL); Carlos Eduardo dos
Santos Ferreira has received speaker’s honoraria from Abbott
Diagnostics, Roche Diagnostics and Siemens Healthineers; Jacques
Izopet has received grants from Roche Diagnostics; Elitza
Theel has received consulting fees from EUROIMMUN US, Serimmune and
Roche Diagnostics, speaker’s honoraria from the American Society for
Microbiology and EUROIMMUN US, and support for meetings from the
American Society for Microbiology, the New York City Branch of the
American Society of Microbiology and the Pan American Society for
Clinical Virology; Andreas Wieser has received grants from
numerous different public fundings, including the German Center for
Infection Research, Fraunhofer Gesellschaft, and German Aif and Zim
programs, royalties or licenses from Smart United GmbH, consulting fees
from Roche Diagnostics and Roche Pharma, speaker’s honoraria from BÄMI
and Roche Diagnostics, support for meetings from BÄMI and Roche
Diagnostics, participated in advisory boards for Roche Diagnostics,
declares stock or stock options in Smart United GmbH and Munich
Innovative Biosolutions UG (haftungsbeschrönkt), and has received
reduced rates for materials and equipment from EUROIMMUN and Roche
Diagnostics; Stefan Holdenrieder is a founder of CEBIO and SFZ
BioCoDE.